Investor Relations

BioNeutral is Committed to Increasing Shareholder Value.

Innovation That Drives Profitability and Shareholder Value

As a publicly traded company (OTC/BB: "BONU"), BioNeutral Group is completely committed to resarch, development, commercialization and marketing of innovative products that serve the infection control community and drive steady growth to the bottom line.  BioNeutral takes a conservative approach to creating, increasing and protecting shareholder value through careful and well-controlled execution of our operational, development and marketing programs.

We Really Want to Hear From You

Our shareholders are essential to our success.  At BioNeutral, we believe in accurate, open and complete representation of the Company's status and milestones.  Dialog with our investor base is a critical component of building a strong company.  Current and prospective investors are strongly encoruaged to contact us at any time for further information, to obtain the latest reports, and discuss investment opportunities.  We look forward to hearing from you.

How To Contact BioNeutral Group

We are committed to prompt response to all investor-related inquiries.  For easiest communication, please simply clik the 'Contact Us' link at the top of this page.  If you have an urgent requirement, please do not hesitate to contact us directly at:

Phone: 973.577.8003

FAX: 973.577.8004

Email: contact@bioneutral.com

Document Downloads

Stockholders Letter

2013 Stockholders Letter: download

S-1

2013 Form S-1 – XBRL: view   download

10-K

2012 Form 10-K – XBRL: view   download

2011 Form 10-K – XBRL: view   download

10-Q

2013 Q1 Form 10-Q – XBRL: view   download

2012 Q1 Form 10-Q – XBRL: view   download

2012 Q2 Form 10-Q – XBRL: view   download

2012 Q3 Form 10-Q – XBRL: download